Nurix Therapeutics Inc. (NRIX) Statistics & Valuation Metrics - Stocknear

Nurix Therapeutics Inc.

NASDAQ: NRIX · Real-Time Price · USD
8.93
0.60 (7.20%)
At close: Sep 26, 2025, 3:59 PM
8.93
0.00%
After-hours: Sep 26, 2025, 04:20 PM EDT

Nurix Therapeutics Statistics

Share Statistics

Nurix Therapeutics has 76.45M shares outstanding. The number of shares has increased by 18.36% in one year.

76.45M
18.36%
0.46%
99.99%
74.92M
195
0.02%

Short Selling Information

The latest short interest is 13.05M, so 17.06% of the outstanding shares have been sold short.

13.05M
17.06%
20.05%
15.21

Valuation Ratios

The PE ratio is -7.67 and the forward PE ratio is -2.33. Nurix Therapeutics's PEG ratio is -0.88.

-7.67
-2.33
27.21
10.3
2.82
-8.16
-0.88
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Nurix Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.46, with a Debt / Equity ratio of 0.05.

6.46
6.46
0.05
-0.14
-0.16
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$190.73K
$-676.81K
286
0.08
n/a

Taxes

270K
-0.14%

Stock Price Statistics

The stock price has increased by -61.26% in the last 52 weeks. The beta is 2.1, so Nurix Therapeutics's price volatility has been higher than the market average.

2.1
-61.26%
9.94
13.21
47.2
908,569

Income Statement

In the last 12 months, Nurix Therapeutics had revenue of 54.55M and earned -193.57M in profits. Earnings per share was -2.88.

54.55M
38.12M
-213.03M
-193.57M
-196.6M
-213.03M
-2.88
Full Income Statement

Balance Sheet

The company has 110M in cash and 28.3M in debt, giving a net cash position of 81.69M.

110M
28.3M
81.69M
-738.77M
591.55M
439.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -172.58M and capital expenditures -9.27M, giving a free cash flow of -181.86M.

-172.58M
-9.27M
-181.86M
-2.71
Full Cash Flow Statement

Margins

Gross margin is 69.88%, with operating and profit margins of -390.52% and -354.85%.

69.88%
-390.52%
-354.36%
-354.85%
-360.41%
-390.52%
-333.38%

Dividends & Yields

NRIX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for NRIX is $30, which is 235.9% higher than the current price. The consensus rating is "Buy".

$30
235.9%
Buy
14
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

0.43
3